Ex Parte Boutin - Page 10


              Appeal No. 2006-1879                                                               Page 10                
              Application No. 10/010,114                                                                                

                     The Fisher court considered the applicant’s argument that an EST is a research                     
              tool, like a microscope, but found the analogy inapt:  “[A] microscope has the specific                   
              benefit of optically magnifying an object to immediately reveal its structure.  One of the                
              claimed ESTs, by contrast, can only be used to detect the presence of genetic material                    
              having the same structure as the EST itself.  It is unable to provide any information                     
              about the overall structure let alone the function of the underlying gene.”  Id. at 1373, 76              
              USPQ2d 1231.  The court concluded that “Fisher’s asserted uses are insufficient to                        
              meet the standard for a ‘substantial’ utility under § 101.”  Id. at 1373, 76 USPQ2d 1231.                 
                     The ESTs at issue in Fisher lacked substantial utility because they were useful                    
              only for conducting experiments on the genes of which the ESTs were part; they were                       
              not useful for conducting research generally but only for conducting research to learn                    
              more about the ESTs themselves and the genes from which they were derived.  Here,                         
              by contrast, the claimed method is broadly useful for transferring nucleic acids into cells.              
              The instant claims are directed to a completed invention, not a “research intermediate”                   
              as in Fisher, that can be used to carry out research using a variety of nucleic acids,                    
              cells, and subjects.  Thus, the instantly claimed method is a valid research tool that can                
              be used to carry out research in general rather than research limited to discovering                      
              information about the claimed invention itself.                                                           
                                                      Summary                                                           
                     We do not agree with the examiner that enabling the instant claims requires                        
              enabling therapeutically effective gene therapy.  The specification provides adequate                     
              guidance to enable those skilled in the art to use the claimed method to transfer nucleic                 







Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next 

Last modified: November 3, 2007